Compare Marqeta Inc (MQ) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Marqeta Inc trades at $18.11 (market cap $1.82B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 13.9× Marqeta Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marqeta Inc for 44 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MQ | RPRX | |
|---|---|---|
Market Cap | $1.82B | $25.27B |
Volume | 1,126,466 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $20.32 | $63.96 |
52-Week Low | $15.04 | $35.44 |
Typical Hold Time | 44 Days | 1 Days |
Enterprise Value | $1.13B | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marqeta (MQ) trades at $17.44, up 2.23% today, showing strong momentum after beating earnings expectations for three consecutive quarters. The stock displays a bullish technical outlook with positive moving average signals, though valuation metrics remain elevated with a P/E of 193.83. Recent partnerships with BVNK for stablecoin cards and Google for kids' wallets highlight ongoing business expansion despite mixed analyst sentiment.
MQ presents a high-risk, high-reward opportunity with improving fundamentals but premium valuation. Revenue growth has recovered from 2024 lows, and cash flow turned positive in 2025. However, the stock trades above most analyst targets, and contract renewals in Q3 2026 create near-term uncertainty. Investors should weigh growth potential against valuation concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
